ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

April 17, 1987

In Brief: Clarke, Einstein Lead ACCC; Changes At CCSG, Cohen Leaves USC For Childhood Foundation

April 17, 1992

UCSF Gets $20 Million For Stem Cell Research Building

February 4, 2011

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006